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In Africa, Asia, Latin America, and parts of Oceania, envenoming after snakebite is a serious
public health problem [1]. Conservative data suggest that between 1.2 and 5.5 million people
suffer snakebites every year, resulting in 25,000 to 125,000 deaths and leaving approximately
400,000 victims with permanent sequelae [2,3]. Despite its significant impact on human health,
this disease remains largely neglected by national and international health authorities, funding
agencies, pharmaceutical companies, patients’ organizations, and health advocacy groups [1,2].
Most initiatives aiming to study snakes, snake venoms, and snakebite envenoming and its
treatment approach the problem from a biomedical and technological perspective. Notwith-
standing the substantial scientific and clinical legacy generated through this view, significant
gaps remain in our understanding of other highly relevant aspects of this problem and its solu-
tions. The emerging field of global health has brought about a more holistic approach to health
issues by incorporating a “biosocial approach” to the understanding of diseases and the cir-
cumstances behind their occurrence [4]. The centrepiece of this approach is the integration of
biomedical aspects—including etiology, pathophysiology, diagnosis, and therapy—with the
analysis of the social, economic, psychological, cultural, and political contexts in which diseases
occur. Snakebite envenoming is predominantly a disease of the poor [5], with the highest inci-
dence and severity seen in regions facing complex and interrelated social and economic prob-
lems. Understanding how this interplay of variables influences both the circumstances leading
to snakebite injury and its consequences is crucial to developing successful strategies to miti-
gate the problem. A comprehensive multidisciplinary approach incorporating social research
into the study of snakebite envenoming is needed. Hereby, we aim to increase awareness of the
following areas where reinvigorated social research would be highly beneficial.
Dimensioning the Magnitude and Social Implications of the
Snakebite Problem
A key issue undermining advocacy efforts to measure the impact of snakebite envenoming
worldwide is the poor level of information on incidence, mortality, sequelae, and social suffer-
ing associated with this disease. Most studies are based on hospital statistics that greatly
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underestimate the burden. Well-designed, adequately powered, community-based surveys of
snakebite incidence and mortality are required to provide reliable data (see [6,7], for example).
One key morbidity indicator, the Disability Adjusted Life Year (DALY), is rarely used to
appreciate the impact of snakebite envenoming. We stress the need to evaluate the degree of
broader “social suffering,” i.e., the effects on people with personal and economic links to the
envenomed person. Gathering this information will be possible by using community surveys
and household interviews to collect data on the circumstances of the bites, whether the victim
attended health facilities, the extent and type of attention provided by local traditional healers,
and the consequences and sequelae of envenoming, including physical, psychological, and eco-
nomical aspects. We recommend that these surveys also identify socio-ethnic, occupational,
biogeographic, and behavioural factors that remain undetected in conventional hospital-based
or national-level public health data. These efforts should also shed light on the incidence of
post-envenoming disability, both temporary and permanent. Few studies highlight the large
impact of physical, psychological, and economic sequelae that result from snakebites [8,9].
Identifying Barriers to Antivenom Access
Availability and accessibility of antivenoms is limited in sub-Saharan Africa, Asia, and, to a
lesser extent, Latin America [2]. Such shortages lead to a vicious cycle whereby poor supply
results in higher prices and lower confidence in the public health sector’s ability to provide
effective and safe antivenoms [10,11]. We stress that a thorough understanding of the mecha-
nisms of pharmaceutical supply, distribution, and affordability in regions with limited access
to antivenom is crucial for devising improved accessibility strategies. Concomitantly, there is a
need for economic analysis of both the sustainability of antivenom supply systems and the
modelling of new economic strategies for financing production, distribution, and supply
through to the end users. Cost-effectiveness studies of antivenom treatment should also be pro-
moted [12]. Comparisons of approaches used for vaccines and other biologicals may provide
useful insights. We trust that renewed research efforts on these topics will help in designing
novel strategies for improving antivenom availability and accessibility.
Exploring the Access to Health Services
Snakebite envenomings are medical emergencies that require prompt medical attention.
Hence, a key issue for reducing their biosocial impact is rapid access to effective healthcare. In
many snakebite-affected countries, an envenomed victim may need to walk (or be carried) for
many kilometres to reach a primary health post. Thus, studies of the circumstances that delay
the access of people bitten by a snake to health centres are of great value. Moreover, having
antivenom in stock is not the complete answer. Rural health facilities also require the proper
storage infrastructure, which encompasses cold-chain procedures and equipment and access to
the other medicines, equipment, and consumables that are necessary to administer antivenom.
Beyond initiating treatment, reliable communications infrastructures, transport routes, and
ways to ensure the safe transfer of envenomed patients to advanced facilities are all needed
[13]. We urge research on the organization of public health services and infrastructure in
regions of high incidence of snakebites, as well as on issues associated with medical training
and antivenom supply and use. Innovative schemes are needed and they require field studies,
such as the centralized “hub-and-spoke” strategy proposed for Nigeria, which not only broad-
ens antivenom access but also implements quality assurance, standardization, and training of
health staff [14]. Likewise, a “diagonal” approach in primary health care should be explored, in
which the prevention and treatment of envenomings parallel the general strengthening of pub-
lic health systems.
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Improving the Training of Health Staff: How to Organize Teaching
Activities Tailored to Local Needs
The skills of personnel at all levels of the health system are critical determinants of effective
snakebite envenoming treatment. While much of this education needs to be integrated into the
curricula of medical and nursing schools, it should also be included in continuing medical edu-
cation programs, especially in areas where envenoming is common. Training programs should
be designed around robust performance indicators that can be regularly evaluated to assess
teaching outcomes, and evaluate the currency and appropriateness of their content. To this
end, the preparation of national or regional guidelines for the diagnosis and treatment of
snakebite envenomings is of utmost relevance. The design of training curricula should be
guided by baseline research aimed at determining the current level of staff knowledge in differ-
ent roles and settings. Information and communication technologies open the door to much
wider dissemination of standard protocols; the selection of the particular technologies imple-
mentable in each local setting should be supported by a knowledge-based approach strength-
ened by renewed research initiatives.
Understanding the Impact of the Local Context: The Perception of
Snakebite in Different Cultural Settings
One of the great failures of “vertical,” top–down interventions in public health issues is the lack
of understanding of the way local communities perceive health problems. Consequently, snake-
bite prevention and intervention programs at the community level should include in-depth
analyses of the cultural characteristics of the communities, the way snakes and snakebites are
perceived, the cultural background of local healers, and the perception of state-based, western-
ized medical services. The reasons why people bitten by snakes do not attend local facilities
should be thoroughly investigated. In this context, ethno-anthropological research is a priority
and should be readily implemented in regions of high snakebite incidence.
Designing Strategies to Improve Prevention and Early
Management: How Do Communities Organize Help for Snakebite
Victims?
The two most critical aspects of any comprehensive snakebite management strategy linked to
local settings and community organizations are prevention and early management of cases.
Public campaigns for snakebite prevention require a detailed knowledge of the cultural features
of rural communities and their organization and leadership through anthropological research.
The use of local languages and dialects, and the involvement of the local population in the com-
munity programs, should be incorporated at early stages in prevention efforts. In general, the
active engagement of communities in the development of health intervention programs greatly
increases the likelihood of success [15].
Final Remarks
We wish to stress that the approaches to confront snakebite envenoming as a public health
problem must go beyond the biomedical and technological paradigms and should encompass
socio-ethnic, socio-economic, and anthropological perspectives. The integration of natural and
social sciences in the study of snakebite envenoming, in association with community-based,
national, and international advocacy efforts, will certainly bring a fresh and renewed perspec-
tive towards understanding and reducing the dramatic burden of this complex and neglected
health problem.
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